Protara Therapeutics, Inc.
TARA • NASDAQ • Stock Fundamentals
Protara Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jesse Shefferman, with a market cap of $276.5M.
Market Cap$276.5M
Employees27.0
CEOJesse Shefferman
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026
View reportNext EarningsAug 10, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Protara Therapeutics, Inc. FAQ
Common questions about Protara Therapeutics, Inc.
Protara Therapeutics, Inc. (TARA) has a market capitalization of $276.5M and trades on NASDAQ.
Protara Therapeutics, Inc. has approximately 27 employees.